Madbris Life Sciences Private Limited
About Madbris Life Sciences Private Limited
Data last updated:
Madbris Life Sciences Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2018PTC045369. Its GSTIN is 23AALCM7112M1ZB (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mayur Runija and Deepak Kumar Jadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No/Plot No.21 – A Fourth Floor Dawa Bazar 13 – 14 R.N.T Marg Indore (Mp), Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.87 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹91,430 (net margin 0.3%) and EBITDA of ₹8.49 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 20% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Madbris Life Sciences Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No/Plot No.21 – A Fourth Floor Dawa Bazar 13 – 14 R.N.T Marg Indore (Mp), Madhya Pradesh, India – 452001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Madbris Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Madbris Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Madbris Life Sciences Private Limited, buy the company report.
Financials of Madbris Life Sciences Private Limited
FY 2025 filings availableMadbris Life Sciences Private Limited reported revenue of ₹2.87 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 12% growth in the latest year. EBITDA rose 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹91,430 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Madbris Life Sciences Private Limited, buy the company report.
Board of directors of Madbris Life Sciences Private Limited
Madbris Life Sciences has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mayur Runija Also directs: Sandblock Realty LLP | Director | 21 Mar 2018 | 8 Years 7 Months | Current |
| Deepak Kumar Jadav | Director | 21 Mar 2018 | 8 Years 7 Months | Current |
| Satish Kumar Jaimini Also directs: Nistalcure Pharma Private Limited | Director | 21 Mar 2018 | 8 Years 7 Months | Current |
| Brijesh Jaiswal | Director | 21 Mar 2018 | 8 Years 7 Months | Current |
| Hemant Mori Kumar | Director | 10 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Madbris Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shamshree International Private Limited | ₹2.87 Cr (FY 2025) | 182.0% | Chandigarh, India | |||
| Madbris Life Sciences Private Limitedthis company | ₹2.87 Cr (FY 2025) | ₹91,430 | 0.3% | 12.0% | Indore, Madhya Pradesh, India | |
| Notion Pharma Private Limited | ₹2.86 Cr (FY 2024) | 410.0% | Indore, Madhya Pradesh, India | |||
| Udik Pharmaceuticals Private Limited | ₹2.86 Cr (FY 2025) | -2.0% | Bareilly, Uttar Pradesh, India | |||
| Moral Nutraceuticals Private Limited | ₹2.86 Cr (FY 2025) | 6.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Madbris Life Sciences Private Limited, buy the company report.
Auditor
Madbris Life Sciences Private Limited is audited by BHANDARI JAIN & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHANDARI JAIN & CO | FY 2019 | 012557C |
Shareholding
The shareholding of Madbris Life Sciences Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Madbris Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Madbris Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Madbris Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Madbris Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AALCM7112M1ZB | Madhya Pradesh | Active | 09 Jun 2018 |
To see the full GST registrations and return filing status of Madbris Life Sciences Private Limited, buy the company report.
Recent activity
Madbris Life Sciences Private Limited has 5 board changes on record since 2018: 5 appointments. The latest: Hemant Mori Kumar was appointed as Director on 10 Jan 2019.
Frequently asked questions
Madbris Life Sciences is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 March 2018 (8+ years old) and is registered under CIN U74999MP2018PTC045369.
Madbris Life Sciences has 5 current directors:
- Mayur Runija - Director
- Deepak Kumar Jadav - Director
- Satish Kumar Jaimini - Director
- Brijesh Jaiswal - Director
- Hemant Mori Kumar - Director
The latest financial statements of Madbris Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Madbris Life Sciences is 23AALCM7112M1ZB, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Madbris Life Sciences is U74999MP2018PTC045369. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Madbris Life Sciences was incorporated on 21 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Madbris Life Sciences by revenue are Shamshree International Private Limited, Notion Pharma Private Limited, Udik Pharmaceuticals Private Limited, Moral Nutraceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Hemant Mori Kumar was appointed as Director on 10 Jan 2019. Brijesh Jaiswal was appointed as Director on 21 Mar 2018. Deepak Kumar Jadav was appointed as Director on 21 Mar 2018. Madbris Life Sciences has 5 board changes on record in total.
The registered office of Madbris Life Sciences is at Shop NoPlot No.21 – A Fourth Floor Dawa Bazar 13 – 14 R.N.T Marg Indore Mp, Madhya Pradesh, India – 452001.
Madbris Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Madbris Life Sciences is compliant as of 15 July 2026. The company is actively filing with the Registrar of Companies.